Skip to main content
. 2019 Apr 18;8(4):534. doi: 10.3390/jcm8040534

Table 4.

Impact of psychotropic medications on BMI, neck, waist, and hip circumferences, FEV1 (%), FVC (%), AHI, meanSaO2 (%), minSaO2 (%), and time spend with SaO2 < 90% during sleep.

Variable Medication Group p Value η2 (Effect Size)
N03
(n = 2)
N05
(n = 6)
N06
(n = 29)
N03, N05
(n = 5)
N03, N06
(n = 7)
N05, N06
(n = 21)
N03, N05, N06
(n = 15)
BMI (kg/m2) 28.6 ± 2.9 29.8 ± 6.0 30.2 ± 7.1 32.3 ± 5.8 32.8 ± 3.5 34.4 ± 5.5 35.7 ± 6.3 0.078 0.132
Neck circumference (cm) 42.0 ± 8.5 43.3 ± 7.3 38.5 ± 4.3 40.2 ± 4.8 42.9 ± 5.9 42.0 ± 4.0 41.1 ± 5.2 0.128 0.120
Waist circumference (cm) 109.5 ± 3.5 113.3 ± 12.3 106.1 ± 16.0 115.2 ± 16.8 117.1 ± 13.2 117.0 ± 11.6 119.8 ± 10.6 0.046 0.151
Hip circumference (cm) 103.5 ± 7.8 110.8 ± 8.2 108.8 ± 11.4 112.8 ± 4.8 116.4 ± 9.3 116.4 ± 14.2 118.9 ± 11.6 0.091 0.131
FEV1 (%) 113.2 ± 26.2 82..4 ± 19.3 97.0 ± 12.7 86.2 ± 15.2 97.3 ± 15.6 90.4 ± 18.2 87.2 ± 16.1 0.091 0.129
FVC (%) 110.6 ± 5.7 81.1 ± 16.6 97.8 ± 14.3 83.1 ± 14.7 96.9 ± 15.7 89.1 ± 18.4 85.0 ± 14.9 0.027 0.165
AHI 31.8 ± 0.0 55.8 ± 32.0 31.3 ± 21.6 53.1 ± 50.9 50.1 ± 32.2 24.0 ± 18.9 32.1 ± 26.5 0.058 0.146
meanSaO2 (%) 95.0 ± 0.0 88.7 ± 4.4 92.6 ± 2.5 92.9 ± 2.4 92.6 ± 1.9 92.3 ± 3.0 91.3 ± 3.2 0.077 0.138
minSaO2 (%) 93.0 ± 0.0 76.0 ± 13.3 85.5 ± 5.7 83.2 ± 8.3 81.7 ± 7.3 83.3 ± 6.7 80.9 ± 10.7 0.131 0.120
time with SaO2 < 90% (min) 0.0 ± 0.0 58.3 ± 44.5 8.6 ± 14.6 14.6 ± 15.7 14.2 ± 12.8 18.3 ± 31.4 25.2 ± 32.8 0.006 0.211

AHI: Apnea-Hypopnea Index, BMI: Body Mass Index, FVC: Forced Vital Capacity, FEV1: Forced Expiratory Volume in 1s, SaO2: Oxyhemoglobin Saturation. Considering the existence of multiple comparisons, the Bonferroni correction (i.e., alpha level/number of comparisons, i.e., 0.05/10) was applied setting the significance level, respectively, to p = 0.005.